NCT01695005 2025-12-26A Study of LY3039478 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed247 enrolled 53 charts
NCT02784795 2025-08-21A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Terminated94 enrolled 28 charts